| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |